glp-1 news 2025 october 16 insurance coverage worsened at start of 2025, report says GLP-1 Trends: Access & Shortages,

They're focused on keeping you hooked on quick fixes, more pills, more highly processed comfort foods, and more products that turn feeling unwell into a business model

The problem is that we do not know much about GLP-1A toxicity

without patients, none of us will be around

Key evidence supporting the notion came from the SELECT trial, which included 17,604 participants aged 45 and older from over 800 locations, recently demonstrated that weekly subcutaneous injections of 2.4 mg of semaglutide significantly reduced MACEs by 20% compared to a placebo in overweight and obese individuals with existing atherosclerotic CVD but no diabetes [26]

And patients need year-round treatment

These lawsuits have led to substantial settlements, including a recent $1.18 billion agreement benefitting 300 water providers nationwide